Stay updated with breaking news from Roche Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In an observational cohort study, Hongjiang Wu and colleagues analyse data from more than 1.5 million people Hong Kong between 2002 and 2018 and compare age- and sex-specific rates of all-cause and cause-specific hospital bed-day rates in those with and without type 2 diabetes.
Objectives To quantify mortality rates for patients successfully treated for hepatitis C in the era of interferon-free, direct acting antivirals and compare these rates with those of the general population. Design Population based cohort study. Setting British Columbia, Scotland, and England (England cohort consists of patients with cirrhosis only). Participants 21 790 people who were successfully treated for hepatitis C in the era of interferon-free antivirals (2014-19). Participants were divided into three liver disease severity groups: people without cirrhosis (pre-cirrhosis), those with ...
/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the expansion of their Global Business Partnership Agreement with Sysmex. As part of the...
Expanded alliance includes an agreement on eco social collaboration to jointly foster more sustainable diagnostic solutions, and the renewal of an agreement on hematology solutions for commercial and hospital
Ozona, Texas -based Ozona Organics, LLC is recalling select probiotic products for human and animal use citing potential to become contaminated with microbial growth, the U.